Condensed Consolidated Statements of Changes in Shareholders' Equity/(Deficit) - USD ($)	Preferred Stock Series D Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balance at Dec. 31, 2022		$ 2,909	$ 217,064,964	$ 24,747	$ (219,563,446)	$ (2,470,826)
Balance (in shares) at Dec. 31, 2022		2,908,578
Balance at Dec. 31, 2022	$ 43
Sale of common stock pursuant to B. Riley At Market Issuance Sales Agreement		$ 21	70,709			70,730
Sale of common stock pursuant to B. Riley At Market Issuance Sales Agreement (in shares)		21,195
Issuance of common stock pursuant to B. Riley At Market Issuance Sales Agreement			(2,341)			(2,341)
Declaration of Series D preferred stock	$ (43)
Share-based compensation expense			73,634			73,634
Foreign currency translation adjustment				(12,153)		(12,153)
Net loss					(1,046,109)	(1,046,109)
Balance at Mar. 31, 2023		$ 2,930	217,206,966	12,594	(220,609,555)	(3,387,065)
Balance (in Shares) at Mar. 31, 2023		2,929,773
Balance at Dec. 31, 2023		$ 10,378	228,193,977	22,243	(225,704,176)	2,522,422
Balance (in shares) at Dec. 31, 2023		10,378,238
Issuance of common stock associated with conversion of debt		$ 146	99,270			99,416
Issuance of common stock associated with conversion of debt (in shares)		146,199
Share-based compensation expense			59,961			59,961
Foreign currency translation adjustment				1,900		1,900
Net loss					(1,915,327)	(1,915,327)
Balance at Mar. 31, 2024		$ 10,524	$ 228,353,208	$ 24,143	$ (227,619,503)	$ 768,372
Balance (in Shares) at Mar. 31, 2024		10,524,437